Friends of Cancer Research’s Post

At the recent Mobile in Clinical Trials and DPHARM conferences in Philadelphia, VivoSense’s Rob Wilson, VP of Commercial Strategy, joined panel discussions on advancing patient engagement, streamlining trial processes, and enhancing ROI in digital health technology. Key insights from these events emphasize the importance of measuring what truly matters to patients, establishing clear ROI for implementing digital health technologies, and the need for proactive change management. With support from regulatory bodies like the FDA, and ongoing validation efforts, the path toward impactful, patient-centered clinical trials is becoming clearer. Get Insights: https://hubs.la/Q02X0R2g0 #clinicalresearch #clinicaltrials #digitalendpoints #digitalbiomarkers

Explore the latest on the EU In Vitro Diagnostic Regulation with our library of resources! Join the IVDR Sprint to receive new articles, webinars and other content directly in your inbox. Find all the details 👉 https://hubs.la/Q02lY5Jg0 #IVDR #technicaldocumentation #IVD #regulatorycompliance

🚀 Join the Discussion on Diagnostics Regulation Reform! 🧬 As you know clinical diagnostics shape 70% of healthcare decisions, yet regulatory frameworks are struggling to meet market needs. Congress has put out an RFI (see below) to seek our input. 🔍 Crucial questions US Congress is seeking input on: - FDA's role in diagnostics oversight (ex. LDTs) - Integration of AI in regulatory processes - Streamlining approvals for special populations - Expanding diagnostic settings like point-of-care tests 💡 Our input matters! Submit responses to diagnostics@help.senate.gov by April 3, 2024. Let's shape the future of healthcare together! #DiagnosticsReform #HealthcareInnovation #RegulatoryFramework Original RFI: https://lnkd.in/eiFQ4Ns7

Casting a wider net will make it possible to choose endpoints that measure what’s most important for the real-world success of a treatment. It will also enable researchers to design protocols that are feasible, patient-friendly and scientifically rigorous—balancing the needs of diverse groups to create value for everyone involved in the healthcare ecosystem. #systemthinking #clinicaltrials

In the push for greater patient-centricity, today’s clinical trials are embracing the use of digital health technologies (DHTs) more than ever. In this Drug Development & Delivery article, IQVIA’s Dr. Tapan Raval and Dr. Ganesh Gundi discuss key considerations for sponsors, CRO partners, and site teams when incorporating digital endpoints into trial design. https://bit.ly/3WDuoUG #digitalhealth #patientcentric #clinicaltrials

Insightful article for anyone interested in continuing to drive innovation in clinical research through the use of digital health technology! Well done Dr. Tapan Raval and Ganesh Gundi !!

Are you curious about how cutting-edge research is accelerating the discovery of new treatments? Adaptive clinical trials are changing the medical field by increasing efficiency, reducing risks, and personalizing patient care. These trials adjust based on real-time data, making them more flexible and effective in various situations, including pandemics. With benefits like quicker development of therapies, ethical improvements, and enhanced collaboration, adaptive trials are setting new standards in clinical research. #ClinicalTrials #AdaptiveTrials

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li. https://ow.ly/lAec50TmOK3 #ClinicalTrials #HealthTech #PharmaInnovation #ClinicalResearch

In the push for greater patient-centricity, today’s clinical trials are embracing the use of digital health technologies (DHTs) more than ever. In this Drug Development & Delivery article, IQVIA’s Dr. Tapan Raval and Dr. Ganesh Gundi discuss key considerations for sponsors, CRO partners, and site teams when incorporating digital endpoints into trial design. https://bit.ly/43yVGgD #patientcentric #clinicaltrials #digitalhealth

📢 In case you missed it, our Founder and President Gen Li, PhD, MBA spoke to The Medicine Maker about how #DigitalTwinTechnology is transforming clinical trials. Check out the full article below. 👇 #ClinicalTrials #AI #DigitalTwins #Data #PatientCare